Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Erratum for Changelian et al., Blood 111 (4) 2155-2157.
Blood, 1 October 2009, Vol. 114, No. 14, pp. 3132.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

ERRATA

Changelian et al. The specificity of JAK3 kinase inhibitors. Blood. 2008;111(4):2155–2157.

On pages 2155 and 2157 of the February 15, 2008, issue, an author name and his authorship contribution were omitted and there is an incorrect notation. The errors were corrected in the online version, which now differs from the print version.

David A. Whipple should have been listed as the seventh author in the author list. The correct author list is shown:

Paul S. Changelian,1 Deborah Moshinsky,1 Cyrille F. Kuhn,1 Mark E. Flanagan,1 Michael J. Munchhof,1 Thomas M. Harris,1 David A. Whipple,1 Jonathan L. Doty,1 Jianmin Sun,1 Craig R. Kent,1 Kelly S. Magnuson,1 David G. Perregaux,1 Perry S. Sawyer,1 and Elizabeth M. Kudlacz1

1Pfizer Global Research and Development, Groton, CT

In "Methods" on page 2155, in the second sentence under the heading "Cellular assays," "1 mg/mL final concentration" should have appeared as "1 µg/mL final concentration." The correct sentence should read: Human whole blood assay: Anti-CD3{epsilon} (R&D Systems, Minneapolis, MN; 1 µg/mL final concentration), anti-CD28 (BD Biosciences, San Jose, CA; 10 ng/mL final concentration) IL-2 (R&D Systems, 10 ng/mL final concentration) were added to heparinized whole blood diluted 1:1 in RPMI 1640 and incubated at 37°C for 18 hours.

On page 2157, the Authorship contribution of David A. Whipple was omitted. The correct Authorship section should read: Contribution: P.S.C. conceived the studies and wrote the paper; D.M. and K.S.M. performed kinase assays; C.F.K. cowrote the paper; M.E.F. and M.J.M. conceived the studies; T.M.H., J.L.D., D.A.W., and J.S. synthesized compounds; C.R.K. and D.G.P. performed cellular assays; P.S. performed in vivo assays; and E.M.K. conceived the studies and cowrote the paper.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020